Proof of principle in the selective treatment of cancer by antibody-directed enzyme prodrug therapy: the development of a highly potent prodrug.

Autor: Tietze LF; Institut für Organische Chemie der Georg-August-Universität Göttingen, Tammannstrasse 2, 37077 Göttingen, Germany. ltietze@gwdg.de, Feuerstein T, Fecher A, Haunert F, Panknin O, Borchers U, Schuberth I, Alves F
Jazyk: angličtina
Zdroj: Angewandte Chemie (International ed. in English) [Angew Chem Int Ed Engl] 2002 Mar 01; Vol. 41 (5), pp. 759-61.
DOI: 10.1002/1521-3773(20020301)41:5<759::aid-anie759>3.0.co;2-7
Databáze: MEDLINE